Results 1 to 10 of about 171,598 (203)
Editorial: Advances in ocular surface disease [PDF]
Frontiers in Medicine, 2023 Hong Qi +5 more
doaj +4 more sources
Ocular Microbiome in Dupilumab-Induced Ocular Surface Disease. [PDF]
AllergyPatients with moderate–severe atopic dermatitis (AD) receive a great benefit from the use of dupilumab, a human IgG4 monoclonal antibody inhibiting IL-4/IL-13 signaling. However, randomized controlled trials and real-world studies showed, in 30%–50% of cases, the development of dupilumab-induced ocular surface disease (DIOSD), characterized by ...
Leonardi A +4 more
europepmc +5 more sources
Cataract surgery in ocular surface disease
Indian Journal of Ophthalmology, 2023 Cataract surgery, which is the most widely performed ophthalmic procedure, is usually done in the elderly population, who are also prone to ocular surface disorders.
K Priyadarshini +3 more
doaj +3 more sources
Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study [PDF]
Frontiers in EndocrinologyIntroductionGraves' Orbitopathy (GO) is an autoimmune disorder characterized by inflammation of orbital tissues, leading to various ocular manifestations, including ocular surface disease. This cross-sectional study aimed to assess the presence of ocular
Maria Novella Maglionico +7 more
doaj +2 more sources
Ocular surface glycocalyx in health and disease
Frontiers in Cell and Developmental BiologyThe glycocalyx is a dynamic carbohydrate-enriched structure that forms a dense coating on the surface of animal cells, including those at the ocular surface. It plays a critical role in maintaining cellular functions and it has a significant influence in
Rafael Martínez-Carrasco, Ajay Sharma
doaj +3 more sources
Glaucoma and Ocular Surface Disease: More than Meets the Eye
Clinical Ophthalmology, 2022 Gavin Li,1 Esen Karamursel Akpek,2 Sumayya Ahmad1 1Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Ocular Surface Disease Clinic, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore,
Li G, Akpek EK, Ahmad S
doaj +2 more sources
Ocular surface disease related to tisotumab vedotin-tftv [PDF]
Gynecologic Oncology ReportsIntroduction: To report a series of patients who developed ocular surface disease related to tisotumab vedotin-tftv (TV), an antibody-drug conjugate (ADC) approved for the treatment of recurrent or metastatic cervical cancer.
Daniella Lent-Schochet +4 more
doaj +2 more sources
Topical fosaprepitant for the treatment of ocular pain and inflammation
American Journal of Ophthalmology Case Reports, 2023 Purpose: To assess whether topical administration of fosaprepitant improves intractable chronic ocular pain and inflammation. Methods: We report three clinical cases of female patients with drug-resistant ocular pain associated with inflammatory diseases
Giuseppe Suanno +4 more
doaj +1 more source
Frontiers in Medicine, 2023 ObjectivesTo assess the safety, efficacy, patients’ satisfaction and acceptability of Rexon-Eye electrotherapy in treating Asian severe dry eye disease (DED) patients.MethodsProspective parallel-arm pilot study recruiting 40 DED Chinese patients with >
Valencia Hui Xian Foo +8 more
doaj +1 more source
Assessing the ocular surface microbiome in severe ocular surface diseases [PDF]
The Ocular Surface, 2020 There is growing evidence for a critical role of the microbiome in ocular health and disease. We performed a prospective, observational study to characterize the ocular surface microbiome (OSM) in four chronic ocular surface diseases (OSDs) and healthy controls.Sterile swabs were used to collect samples from each eye of 39 patients (78 eyes).
Michael J. Zilliox +6 more
openaire +2 more sources